GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
Yunfei Wang(Affiliated Hospital of Jining Medical University), Qiang Zhan(Wuxi People's Hospital)
Cited by 16
Related Papers
Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer
|Journal of Ovarian Research|2022|22